| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $105,109,892 ) (Continued on the next page) |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AG085152 | Ultrasound for bedside characterization of swallowing biomechanical impairments and biofeedback | 000 | 1 | NIH | 7/18/2024 | $432,534 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AG085052 | The cell-specific neurodegenerative potential of mitochondria post-traumatic brain injury | 000 | 1 | NIH | 7/18/2024 | $158,247 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 001 | 1 | NIH | 7/16/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 000 | 1 | NIH | 12/26/2023 | $441,060 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K08DC020780 | Rational Design of Magnetic Nanoparticles for Cochlear Drug Delivery | 001 | 2 | NIH | 1/11/2024 | $200,880 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 005 | 25 | NIH | 9/12/2024 | $502,744 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 004 | 25 | NIH | 9/6/2024 | $498,507 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 002 | 25 | NIH | 5/3/2024 | $111,484 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 002 | 25 | NIH | 5/3/2024 | $103,765 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 003 | 25 | NIH | 5/13/2024 | $0 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 003 | 25 | NIH | 5/13/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 001 | 25 | NIH | 3/11/2024 | $1,003,352 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 001 | 25 | NIH | 3/11/2024 | $933,883 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr | 000 | 24 | NIH | 1/31/2024 | $146,310 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21HD115776 | Tracking the Development and Influence of Post-Stroke Sensory Reweighting on Walking and Balance Outcomes | 000 | 1 | NIH | 8/2/2024 | $243,000 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI176098 | tRNA modifications as critical components of insect blood feeding and reproduction | 001 | 2 | NIH | 5/21/2024 | $24,300 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI176098 | tRNA modifications as critical components of insect blood feeding and reproduction | 000 | 2 | NIH | 1/24/2024 | $218,700 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01MH130399 | The impact of stress-induced DNA breaks on chromatin structure, gene activity, and neuron function | 001 | 2 | NIH | 7/30/2024 | $78,913 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01MH130399 | The impact of stress-induced DNA breaks on chromatin structure, gene activity, and neuron function | 000 | 2 | NIH | 1/4/2024 | $710,213 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI168979 | Structure-function analysis of a catalase/ankyrin tandem from Pseudomonas aeruginosa necessary for resistance to hydrogen peroxide | 001 | 2 | NIH | 5/13/2024 | $20,250 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI168979 | Structure-function analysis of a catalase/ankyrin tandem from Pseudomonas aeruginosa necessary for resistance to hydrogen peroxide | 000 | 2 | NIH | 10/24/2023 | $182,250 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | RF1NS036695 | Genetic and Environmental Risk Factors for Hemorrhagic Stroke – V | 000 | 20 | NIH | 8/20/2024 | $2,374,719 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI176276 | Early life dysbiosis, and skin barrier function | 001 | 1 | NIH | 9/11/2024 | $21,676 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI176276 | Early life dysbiosis, and skin barrier function | 000 | 1 | NIH | 11/16/2023 | $195,090 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL167024 | CCDC92 and cardiovascular disease | 002 | 2 | NIH | 6/26/2024 | $43,139 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL167024 | CCDC92 and cardiovascular disease | 001 | 2 | NIH | 6/11/2024 | $405,000 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL167024 | CCDC92 and cardiovascular disease | 000 | 2 | NIH | 12/4/2023 | $485,302 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL160811 | Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure | 001 | 3 | NIH | 6/13/2024 | $54,419 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL160811 | Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure | 000 | 3 | NIH | 11/14/2023 | $612,216 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U24NS107241 | Ohio Valley Regional Coordinating Center for NINDS Stroke Trial Network | 003 | 6 | NIH | 4/23/2024 | $72,419 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U24NS107241 | Ohio Valley Regional Coordinating Center for NINDS Stroke Trial Network | 005 | 6 | NIH | 5/1/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U24NS107241 | Ohio Valley Regional Coordinating Center for NINDS Stroke Trial Network | 001 | 6 | NIH | 12/11/2023 | $445,295 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS119827 | Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations | 001 | 3 | NIH | 4/25/2024 | $28,572 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS119827 | Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations | 000 | 3 | NIH | 11/10/2023 | $367,357 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 001 | 3 | NIH | 4/17/2024 | $20,103 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 000 | 3 | NIH | 12/14/2023 | $361,832 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS121426 | Monitoring rapid guanosine signaling during ischemia | 001 | 4 | NIH | 4/25/2024 | $27,038 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS121426 | Monitoring rapid guanosine signaling during ischemia | 000 | 4 | NIH | 1/23/2024 | $347,635 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS120493 | Recovery of StrokE - Longitudinal Assessment With Neuroimaging (ROSE LAWN) | 001 | 4 | NIH | 5/18/2024 | $61,645 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS120493 | Recovery of StrokE - Longitudinal Assessment With Neuroimaging (ROSE LAWN) | 001 | 4 | NIH | 5/18/2024 | $12,988 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS120493 | Recovery of StrokE - Longitudinal Assessment With Neuroimaging (ROSE LAWN) | 000 | 4 | NIH | 12/5/2023 | $554,804 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS120493 | Recovery of StrokE - Longitudinal Assessment With Neuroimaging (ROSE LAWN) | 000 | 4 | NIH | 12/5/2023 | $116,889 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01MH133070 | Airway inflammation and fear: elucidating immune mediators and neural substrates | 001 | 1 | NIH | 9/6/2024 | $0 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01MH133070 | Airway inflammation and fear: elucidating immune mediators and neural substrates | 000 | 1 | NIH | 8/29/2024 | $463,425 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 001 | 2 | NIH | 6/17/2024 | $44,550 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 000 | 2 | NIH | 3/1/2024 | $400,950 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01AG083164 | Investigating the role of CSF production and circulation in aging and Alzheimer's disease | 000 | 2 | NIH | 5/10/2024 | $586,770 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R00HL141626 | Novel Mechanism of RBFox1 Mediated RNA Metabolism in Heart Failure | 000 | 6 | NIH | 4/30/2024 | $249,000 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K23HL151816 | Sex Disparities in Cardiovascular Disease and Optimal Coronary Revascularization in Dialysis Patients | 000 | 4 | NIH | 5/21/2024 | $193,104 |
|
